Company Number: 14459253

Analysis Date: 2025-07-29 12:48 UTC

Financial Health Assessment for SLIMONADE LIMITED

---

1. Financial Health Score: D

Explanation:
SLIMONADE LIMITED is currently a dormant company with almost no financial activity—reflected in minimal cash and net assets of just £1. This score indicates a company in a very early or inactive stage, showing symptoms of "financial hibernation" rather than active financial health. While there are no signs of distress or liabilities, the lack of operating data means there is no financial momentum or vitality to assess.

---

2. Key Vital Signs

Metric	Value	Interpretation
Status	Active	Company is registered and operational.
Account Category	Dormant	No significant trading or financial events.
Cash at bank	£1	Minimal cash reserves, typical for dormant.
Net Assets	£1	Equity represented by a single £1 share.
Shareholders Funds	£1	Reflects initial capital, no retained earnings.
Filings Status	Up to date	No overdue accounts or confirmation statements.
Director & PSC	Single director/owner with full control.	Clear control structure, no complexity.

Interpretation:

• The company's "vital signs" reveal a business in stasis with no operating assets or liabilities.
• Dormant status means no revenue, expenses, or operational cash flow, which is normal at this stage.
• Financially, it is neither healthy nor distressed—more accurately described as "asleep," awaiting activation.
• Filings and compliance are current, indicating good administrative health despite inactivity.

---

3. Diagnosis

SLIMONADE LIMITED currently displays the classic symptoms of a dormant company: negligible financial activity, minimal assets, and no trading history. This is typical for a recently incorporated entity (incorporated Nov 2022) that has yet to commence business operations. The company has no liabilities or debts, which is a positive sign, but also lacks any assets or working capital beyond the initial £1 share capital.

The single director and sole shareholder arrangement simplifies governance but also concentrates all control in one individual, which may affect future strategic decisions.

Overall, the company’s financial condition is stable but inactive. The "patient" is in a state of rest, with no current stressors or symptoms of financial distress but also no indicators of growth or operational health.

---

4. Recommendations

• Activate Operations: To transition from dormancy, begin trading activities, which will introduce revenue, expenses, and operational cash flow—key indicators of financial health.
• Raise Working Capital: Consider injecting working capital to fund initial operations, such as purchasing inventory or marketing expenses, to avoid cash flow constraints.
• Maintain Compliance: Continue filing accounts and confirmation statements on time to avoid penalties and maintain good standing.
• Financial Planning: Develop a detailed business plan including cash flow forecasts, budgeting, and profitability targets. This helps diagnose potential future financial symptoms early.
• Governance: If the company grows, consider appointing additional directors or advisors to diversify oversight and reduce dependency on a single decision-maker.
• Monitor Financial Vital Signs: Once trading starts, regularly review liquidity ratios, profitability, and solvency to ensure the business remains financially healthy.

---